DYN
Dyne Therapeutics, Inc.
+0.50 (+2.86%)17.80USD1.1M成交股數3.3B市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-05下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 46 · 112M · 6 |
| 其中 10b5-1 計畫賣出 | 45 筆 |
| 近 180 天 買進 · 賣出金額 | 191K · 153M |
| 近 180 天 淨額 | −153M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-08 | 09-08 | Kerr Douglas | Chief Medical Officer | S 公開市場賣出(10b5-1) | 1.3K | 18.88 | 24K | 163K | SEC |
| 2026-09-08 | 09-08 | Cox John | CEO & President | S 公開市場賣出(10b5-1) | 5.7K | 18.88 | 107K | 358K | SEC |
| 2026-09-08 | 09-08 | Friedl-Naderer Johanna | Chief Commercial Officer | S 公開市場賣出(10b5-1) | 185 | 18.88 | 3K | 153K | SEC |
| 2026-09-04 | 09-08 | Kerr Douglas | Chief Medical Officer | S 公開市場賣出(10b5-1) | 3.7K | 24.35 | 91K | 164K | SEC |
| 2026-09-04 | 09-08 | Friedl-Naderer Johanna | Chief Commercial Officer | S 公開市場賣出(10b5-1) | 900 | 24.35 | 22K | 153K | SEC |
| 2026-08-14 | 08-17 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 1.4M | 25.00 | 34.0M | 2.4M | SEC |
| 2026-08-14 | 08-17 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 478K | 25.00 | 12.0M | 567K | SEC |
| 2026-08-14 | 08-17 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 322K | 25.00 | 8.1M | 429K | SEC |
| 2026-08-13 | 08-17 | Cox John | CEO & President | S 公開市場賣出(10b5-1) | 5.0K | 26.28 | 131K | 363K | SEC |
| 2026-08-13 | 08-17 | Friedl-Naderer Johanna | Chief Commercial Officer | S 公開市場賣出(10b5-1) | 226 | 26.28 | 6K | 154K | SEC |
| 2026-08-13 | 08-17 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 94.4K | 26.20 | 2.5M | 1.0M | SEC |
| 2026-08-13 | 08-17 | Lucera Erick | Chief Financial Officer | S 公開市場賣出(10b5-1) | 1.8K | 26.28 | 47K | 120K | SEC |
| 2026-08-13 | 08-17 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 268K | 26.20 | 7.0M | 3.8M | SEC |
| 2026-08-13 | 08-17 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 63.6K | 26.20 | 1.7M | 751K | SEC |
| 2026-08-13 | 08-17 | Kerr Douglas | Chief Medical Officer | S 公開市場賣出(10b5-1) | 1.6K | 26.28 | 41K | 168K | SEC |
| 2026-07-27 | 07-29 | Kersten Dirk | Director | S 公開市場賣出(10b5-1) | 5.4K | 26.04 | 140K | 3.6M | SEC |
| 2026-07-27 | 07-29 | Kersten Dirk | Director | S 公開市場賣出(10b5-1) | 256K | 25.50 | 6.5M | 3.6M | SEC |
| 2026-07-07 | 07-08 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 14.8K | 23.62 | 351K | 1.1M | SEC |
| 2026-07-07 | 07-08 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 5.0K | 23.61 | 118K | 3.0K | SEC |
| 2026-07-07 | 07-08 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 49.2K | 23.17 | 1.1M | 827K | SEC |
| 2026-07-07 | 07-08 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 62.5K | 23.17 | 1.4M | 1.2M | SEC |
| 2026-07-07 | 07-08 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 29.6K | 23.62 | 699K | 4.1M | SEC |
| 2026-07-07 | 07-08 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 124K | 23.17 | 2.9M | 4.1M | SEC |
| 2026-07-07 | 07-08 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 11.7K | 23.62 | 276K | 815K | SEC |
| 2026-07-06 | 07-08 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 127K | 22.79 | 2.9M | 1.2M | SEC |
| 2026-07-06 | 07-08 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 100K | 22.79 | 2.3M | 876K | SEC |
| 2026-07-06 | 07-08 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 253K | 22.79 | 5.8M | 4.2M | SEC |
| 2026-06-29 | 06-30 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 103K | 21.14 | 2.2M | 4.5M | SEC |
| 2026-06-29 | 06-30 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 40.7K | 21.14 | 860K | 976K | SEC |
| 2026-06-29 | 06-30 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 51.8K | 21.14 | 1.1M | 1.3M | SEC |
| 2026-06-26 | 06-30 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 64.4K | 21.28 | 1.4M | 1.0M | SEC |
| 2026-06-26 | 06-30 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 81.9K | 21.28 | 1.7M | 1.4M | SEC |
| 2026-06-26 | 06-30 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 163K | 21.28 | 3.5M | 4.6M | SEC |
| 2026-06-25 | 06-26 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 5.0K | 21.10 | 106K | 1.1M | SEC |
| 2026-06-25 | 06-26 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 6.4K | 21.10 | 135K | 1.5M | SEC |
| 2026-06-25 | 06-26 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 12.7K | 21.10 | 268K | 4.7M | SEC |
| 2026-06-25 | 06-26 | Lucera Erick | Chief Financial Officer | S 公開市場賣出 | 2.4K | 20.37 | 48K | 122K | SEC |
| 2026-06-24 | 06-26 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 20.0K | 21.02 | 420K | 1.1M | SEC |
| 2026-06-24 | 06-26 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 25.4K | 21.02 | 534K | 1.5M | SEC |
| 2026-06-24 | 06-26 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 50.5K | 21.02 | 1.1M | 4.8M | SEC |
| 2026-06-23 | 06-26 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 77.9K | 21.13 | 1.6M | 4.8M | SEC |
| 2026-06-23 | 06-26 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 39.1K | 21.13 | 827K | 1.5M | SEC |
| 2026-06-23 | 06-26 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 30.8K | 21.13 | 650K | 1.1M | SEC |
| 2026-06-23 | 06-24 | Kersten Dirk | Director | S 公開市場賣出(10b5-1) | 1.7K | 21.47 | 36K | 3.8M | SEC |
| 2026-06-23 | 06-24 | Kersten Dirk | Director | S 公開市場賣出(10b5-1) | 71.6K | 21.04 | 1.5M | 3.8M | SEC |
| 2026-06-22 | 06-24 | Kersten Dirk | Director | S 公開市場賣出(10b5-1) | 191K | 20.57 | 3.9M | 3.9M | SEC |
| 2026-06-18 | 06-22 | Kersten Dirk | Director | S 公開市場賣出(10b5-1) | 46.9K | 20.07 | 941K | 4.1M | SEC |
| 2026-06-17 | 06-22 | Kersten Dirk | Director | S 公開市場賣出(10b5-1) | 37.5K | 20.14 | 754K | 4.2M | SEC |
| 2026-06-16 | 06-17 | Cox John | CEO & President | S 公開市場賣出(10b5-1) | 2.7K | 18.33 | 49K | 368K | SEC |
| 2026-06-16 | 06-17 | Friedl-Naderer Johanna | Chief Commercial Officer | S 公開市場賣出(10b5-1) | 145 | 18.33 | 3K | 154K | SEC |
| 2026-06-16 | 06-17 | Kerr Douglas | Chief Medical Officer | S 公開市場賣出(10b5-1) | 887 | 18.33 | 16K | 169K | SEC |
| 2026-06-08 | 06-09 | Posner Brian S | Director | P 公開市場買進 | 2.0K | 16.94 | 34K | 24.5K | SEC |
| 2026-06-03 | 06-05 | Posner Brian S | Director | P 公開市場買進 | 2.5K | 17.48 | 44K | 22.5K | SEC |
| 2026-05-26 | 05-28 | Posner Brian S | Director | P 公開市場買進 | 2.0K | 18.21 | 36K | 20.0K | SEC |
| 2026-05-20 | 05-22 | Posner Brian S | Director | P 公開市場買進 | 2.5K | 17.12 | 43K | 18.0K | SEC |
| 2026-05-13 | 05-14 | Cox John | CEO & President | S 公開市場賣出(10b5-1) | 3.3K | 18.36 | 61K | 371K | SEC |
| 2026-05-13 | 05-14 | Kerr Douglas | Chief Medical Officer | S 公開市場賣出(10b5-1) | 1.6K | 18.36 | 29K | 170K | SEC |
| 2026-05-13 | 05-14 | Friedl-Naderer Johanna | Chief Commercial Officer | S 公開市場賣出(10b5-1) | 228 | 18.36 | 4K | 154K | SEC |
| 2026-05-13 | 05-14 | Lucera Erick | Chief Financial Officer | S 公開市場賣出(10b5-1) | 1.4K | 18.36 | 27K | 124K | SEC |
| 2026-05-06 | 05-06 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 17.2K | 18.18 | 313K | 1.1M | SEC |
| 2026-05-06 | 05-06 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 428 | 18.18 | 8K | 8.0K | SEC |
| 2026-05-06 | 05-06 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 43.6K | 18.18 | 793K | 4.9M | SEC |
| 2026-05-06 | 05-06 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 21.9K | 18.18 | 399K | 1.5M | SEC |
| 2026-05-05 | 05-06 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 6.1K | 18.03 | 110K | 4.9M | SEC |
| 2026-05-05 | 05-06 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 3.1K | 18.03 | 55K | 1.6M | SEC |
| 2026-05-05 | 05-06 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 2.4K | 18.03 | 43K | 1.2M | SEC |
| 2026-05-05 | 05-06 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 60 | 18.03 | 1K | 8.4K | SEC |
| 2026-05-04 | 05-06 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 2.5K | 18.00 | 44K | 1.2M | SEC |
| 2026-05-04 | 05-06 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 61 | 18.00 | 1K | 8.4K | SEC |
| 2026-05-04 | 05-06 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 6.2K | 18.00 | 112K | 4.9M | SEC |
| 2026-05-04 | 05-06 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 3.1K | 18.00 | 56K | 1.6M | SEC |
| 2026-04-28 | 04-30 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 119K | 18.38 | 2.2M | 4.9M | SEC |
| 2026-04-28 | 04-30 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 1 | 19.00 | 19.00 | 8.5K | SEC |
| 2026-04-28 | 04-30 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 52 | 19.00 | 988.00 | 4.9M | SEC |
| 2026-04-28 | 04-30 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 26 | 19.00 | 494.00 | 1.6M | SEC |
| 2026-04-28 | 04-30 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 47.1K | 18.38 | 865K | 1.2M | SEC |
| 2026-04-28 | 04-30 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 1.2K | 18.38 | 22K | 8.5K | SEC |
| 2026-04-28 | 04-30 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 21 | 19.00 | 399.00 | 1.2M | SEC |
| 2026-04-28 | 04-30 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 59.9K | 18.38 | 1.1M | 1.6M | SEC |
| 2026-04-27 | 04-27 | Rhodes Jason P | Director | S 公開市場賣出(10b5-1) | 45.7K | 18.15 | 830K | 1.6M | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| BlackRock, Inc. | 12.4M | 276M | 新進 | 新進 |
| Jupiter Topco LLC | 12.0M | 267M | 新進 | 新進 |
| FMR LLC | 11.2M | 249M | 新進 | 新進 |
| STATE STREET CORP | 7.5M | 166M | 新進 | 新進 |
| Orbis Allan Gray Ltd | 7.0M | 156M | 新進 | 新進 |
| Atlas Venture Life Science Advisors, LLC | 6.8M | 151M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.3M | 140M | 新進 | 新進 |
| TCG Crossover Management, LLC | 4.6M | 103M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.0M | 89.9M | 新進 | 新進 |
| FCPM III SERVICES B.V. | 3.8M | 85.5M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 3.7M | 83.2M | 新進 | 新進 |
| Vestal Point Capital, LP | 3.4M | 75.0M | 新進 | 新進 |
| ORBIMED ADVISORS LLC | 3.2M | 71.9M | 新進 | 新進 |
| Frazier Life Sciences Management, L.P. | 3.2M | 70.0M | 新進 | 新進 |
| ARMISTICE CAPITAL, LLC | 3.1M | 68.6M | 新進 | 新進 |
| JPMORGAN CHASE & CO | 3.2M | 67.2M | 新進 | 新進 |
| PERCEPTIVE ADVISORS LLC | 2.7M | 59.7M | 新進 | 新進 |
| Logos Global Management LP | 2.5M | 56.6M | 新進 | 新進 |
| BANK OF AMERICA CORP /DE/ | 2.2M | 49.6M | 新進 | 新進 |
| Venrock Adviser, LLC | 2.2M | 48.3M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 2.2M | 47.9M | 新進 | 新進 |
| Siren, L.L.C. | 2.1M | 47.3M | 新進 | 新進 |
| FRANKLIN RESOURCES INC | 2.0M | 45.1M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 1.9M | 43.2M | 新進 | 新進 |
| MPM BIOIMPACT LLC | 1.9M | 42.7M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 246 +18 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 246 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 191M · 100.0% |
| 合計季末市值 | 3.5B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 20.8M |
|---|---|
| 與上期比 | -3.1% |
| 佔流通股數 | 11.13% |
| 日均成交量 | 1.5M |
| 回補天數 | 13.5 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 20.8M | -3.1% | 11.13% | 1.5M | 13.5 |
| 2026-08-14 | 21.5M | -2.3% | 11.49% | 2.0M | 11.0 |
| 2026-07-31 | 22.0M | +2.2% | 11.76% | 3.1M | 7.2 |
| 2026-07-15 | 21.5M | -3.6% | 11.51% | 2.0M | 10.6 |
| 2026-06-30 | 22.3M | -2.2% | 11.94% | 2.8M | 8.0 |
| 2026-06-15 | 22.8M | +2.4% | 12.22% | 1.6M | 14.3 |
| 2026-05-29 | 22.3M | +6.2% | 11.93% | 1.5M | 14.6 |
| 2026-05-15 | 21.0M | +1.2% | 11.24% | 1.3M | 16.8 |
| 2026-04-30 | 20.7M | -4.5% | 11.10% | 1.8M | 11.5 |
| 2026-04-15 | 21.7M | +6.0% | 11.62% | 1.6M | 13.4 |
| 2026-03-31 | 20.5M | +7.1% | 10.96% | 2.4M | 8.5 |
| 2026-03-13 | 19.1M | -1.1% | 10.23% | 2.9M | 6.6 |
| 2026-02-27 | 19.3M | +0.9% | 10.34% | 1.8M | 10.9 |
| 2026-02-13 | 19.2M | -0.2% | 10.26% | 1.7M | 11.5 |
| 2026-01-30 | 19.2M | +1.6% | 10.28% | 2.1M | 9.1 |
| 2026-01-15 | 18.9M | +9.2% | 10.11% | 2.3M | 8.3 |
| 2025-12-31 | 17.3M | +15.7% | 9.26% | 1.9M | 9.0 |
| 2025-12-15 | 14.9M | -14.4% | 8.01% | 4.2M | 3.6 |
| 2025-11-28 | 17.5M | +2.0% | 9.35% | 2.5M | 7.1 |
| 2025-11-14 | 17.1M | +13.2% | 9.16% | 2.6M | 6.5 |
| 2025-10-31 | 15.1M | -11.6% | 8.10% | 3.2M | 4.7 |
| 2025-10-15 | 17.1M | -3.8% | 9.16% | 2.3M | 7.4 |
| 2025-09-30 | 17.8M | +16.1% | 9.52% | 2.8M | 6.3 |
| 2025-09-15 | 15.3M | -4.6% | 8.19% | 2.0M | 7.6 |
| 2025-08-29 | 16.0M | -6.4% | 8.59% | 2.5M | 6.4 |
| 2025-08-15 | 17.1M | +5.1% | 9.18% | 3.5M | 4.8 |